Abselion
UK-based company which specializes in automated analytical instrumentation that simplifies at-line protein quantification
Abselion has raised €8.0M across 1 funding round from 6 investors, most recently a Series A round in Dec 2024. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKwww.abselion.com ↗
Total raised
€8.0M
€7,970,533
Funding rounds
1
Investors
6
distinct backers
Active since
2024-12
latest 2024-12
Funding by year
EUR raised per yearAbselion — funding by year — interactive chart.
Data table
| Abselion — funding by year | |
|---|---|
| 2024 | €8.0M |
Signals
High confidenceRaise-next likelihood57
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-09 | Series A | €8.0M | BGF,BioProcess 360 Partners,Existing investors,M Ventures,R42 Group,the Untitled | View deal → |